StysPKZamponiGWvan MinnenJ. Will the real multiple sclerosis please stand up?Nat Rev Neurosci2012; 13: 507–501.
2.
LisakRPZweimanBBurnsJB. Immune responses to myelin antigens in multiple sclerosis. Ann N Y Acad Sci1984; 436: 221–230.
3.
HuXPaikPKChenJ. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity2006; 24: 563–574.
4.
KunisGBaruchKRosenzweigN. IFN-γ-dependent activation of the brain’s choroid plexus for CNS immune surveillance and repair. Brain2013; in press.
5.
WangYRenZTaoD. STAT1/IRF-1 signaling pathway mediates the injurious effect of interferon-gamma on oligodendrocyte progenitor cells. Glia2010; 58: 195–208.
6.
GardnerCMagliozziRDurrenbergerPF. Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats. Brain2013; in press.
7.
van NoortJMBakerDAmorS. Mechanisms in the development of multiple sclerosis lesions: Reconciling autoimmune and neurodegenerative factors. CNS Neurol Disord Drug Targets2012; 11: 556–556.
8.
BsibsiMHoltmanIRGerritsenWH. Alpha-B-crystallin induces an immune-regulatory and antiviral microglial response in preactive multiple sclerosis lesions. J Neuropathol Exp Neurol2013; 72: 970–979.
9.
OusmanSSTomookaBHvan NoortJM. Protective and therapeutic role for alpha B-crystallin in autoimmune demyelination. Nature2007; 448: 474–479.
10.
EngelhardtBRansohoffRM. Capture, crawl, cross: The T cell code to breach the blood-brain barriers. Trends Immunol2012; 33: 579–589.